NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 1.088
+0.008 (0.74%)
Sep 2, 2026, 5:08 PM CET
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 137.52 million as of September 2, 2026. Its market cap has increased by 4.62% in one year.
Market Cap
137.52M
Enterprise Value
116.43M
Revenue
10.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.09
ChartMarket Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 137.52M, an increase of 316.39%. That is a compound annual growth rate of 16.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 137.52M | 68.88% |
| Dec 30, 2025 | 81.43M | -60.77% |
| Dec 30, 2024 | 207.58M | 129.58% |
| Dec 29, 2023 | 90.42M | -62.64% |
| Dec 30, 2022 | 242.03M | -9.28% |
| Dec 30, 2021 | 266.79M | -35.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 195.75M |
| Elicera Therapeutics AB | 190.20M |
| Alzinova AB | 170.22M |
| Abera Bioscience AB | 166.86M |
| Nanologica AB | 161.10M |
| Diamyd Medical AB | 160.25M |
| Initiator Pharma | 157.44M |
| Xintela AB | 145.98M |